New hybrid 'NOSH aspirin' as possible anti-cancer drug
2012-03-01
(Press-News.org) Scientists have combined two new "designer" forms of aspirin into a hybrid substance that appears more effective than either of its forebears in controlling the growth of several forms of cancer in laboratory tests. Their report on the new NOSH-aspirin, so named because it releases nitric oxide (NO) and hydrogen sulfide (H2S), appears in the journal ACS Medicinal Chemistry Letters.
Khosrow Kashfi, Ravinder Kodela and Mitali Chattopadhyay point out that NO and H2S are signaling substances produced in the body that relax blood vessels, reduce inflammation and have a variety of other effects. Scientists previously developed designer aspirin that releases NO in an effort to reduce aspirin's potential adverse effects in causing bleeding in the gastrointestinal tract. Another designer aspirin that releases H2S was developed which also has anti-inflammatory properties and appears safe to the stomach.
Since NO and H2S are gases with physiological relevance, and Kashfi's group had previously shown beneficial effects with both NO- and H2S-aspirins, they postulated that a new hybrid that incorporated both of these entities might be even more potent and effective than either one alone. Their hypothesis has proved to be correct.
They found indications that the new hybrid inhibits the growth of breast, colon, pancreas, lung, prostate and some leukemia cancer cells in laboratory tests. Some of the NOSH-aspirins tested were more than 100,000 times more powerful against cancer cell growth than aspirin alone. Promisingly, the group reported that their hybrids did not damage normal cells.
INFORMATION:
The authors acknowledge funding from the National Cancer Institute.
The American Chemical Society is a nonprofit organization chartered by the U.S. Congress. With more than 164,000 members, ACS is the world's largest scientific society and a global leader in providing access to chemistry-related research through its multiple databases, peer-reviewed journals and scientific conferences. Its main offices are in Washington, D.C., and Columbus, Ohio.
To automatically receive news releases from the American Chemical Society contact newsroom@acs.org.
END
ELSE PRESS RELEASES FROM THIS DATE:
2012-03-01
If you have been injured in a motor vehicle accident in Utah, you probably have many things on your mind. You could be worried about:
- Paying your medical bills
- Covering your wages if you are forced to be out of work
- Getting your car repaired
- Having to pay for a rental car
Utah laws mandating specific types of car insurance coverage should allow you to rest easier. Utah is what is known as a "no-fault" automobile insurance state. This means that essentially the law is designed to keep insurance premiums lower by discouraging lawsuits between drivers. ...
2012-03-01
New Orleans, LA – Research led by Nicolas Bazan, MD, PhD, Boyd Professor and Director of the Neuroscience Center of Excellence at LSU Health Sciences Center New Orleans, has found that a synthetic molecule protected the brain in a model of experimental stroke. Dr. Bazan was issued a patent on the molecule called LAU-0901, a low molecular weight drug that crosses the blood-brain barrier. The findings are published in the March 2012 issue of Translational Stroke Research.
During an ischemic stroke, the most common kind, the body releases signals that cause neuroinflammation ...
2012-03-01
Diversity has become a goal for all sorts of institutions—but what it means may depend on who you ask. A new study published in Psychological Science, a journal of the Association for Psychological Science, finds that people's ideologies help determine what they count as "diverse."
Miguel Unzueta, the study's lead author, notes that "diversity" historically meant inclusiveness toward historically disadvantaged groups. Now, however, the term is commonly used to refer to people who are different in any way (even personality traits and food preferences)—and that, Dr. Unzueta ...
2012-03-01
GAINESVILLE, Fla. --- The discovery of two new extinct camel species by University of Florida scientists sheds new light on the history of the tropics, a region containing more than half the world's biodiversity and some of its most important ecosystems.
Appearing online this week in the Journal of Vertebrate Paleontology, the study is the first published description of a fossil mammal discovered as part of an international project in Panama. Funded with a grant from the National Science Foundation, UF paleontologists and geologists are working with the Panama Canal Authority ...
2012-03-01
An inexpensive device used by millions of people with diabetes could be adapted into a home DNA detector that enables individuals to perform home tests for viruses and bacteria in human body fluids, in food and in other substances, scientists are reporting in a new study. The report on this adaptation of the ubiquitous personal glucose monitor, typically used to test blood sugar levels, appears in ACS' journal Analytical Chemistry.
Yi Lu and Yu Xiang point out that developing low-cost tests for the public to use for early diagnosis of diseases, checking the safety of ...
2012-03-01
Almost 80 percent of current farmland in the U.S. would have to be devoted to raising corn for ethanol production in order to meet current biofuel production targets with existing technology, a new study has found. An alternative, according to a study in ACS' journal Environmental Science & Technology, would be to convert 60 percent of existing rangeland to biofuels.
W. Kolby Smith and colleagues explain that the 2007 Energy Independence and Security Act (EISA) set a goal of increasing U.S. biofuel production from 40 to 136 billion gallons of ethanol per year by 2022. ...
2012-03-01
Atlanta window tinting company The Tint Guy reminds homeowners that summer is not the only time to consider protection from the sun. Window tinting for your home, office and vehicle can dramatically reduce harmful exposure to UV rays at any time of the year. Tinted window films also protect the interior of these spaces from wearing out prematurely.
The specialists at The Tint Guy report that most people do not think to have window tinting installed in the winter since the interior of their automobile or home is not as hot. People tend to associate these tinted films ...
2012-03-01
In a modern iteration of the great age of Antarctic exploration of the 19th and 20th centuries, three teams of scientists are rushing to reach not the South Pole like Roald Amundsen, Robert Falcon Scott and Ernest Shackleton, but lakes deep below the surface of the Frozen Continent believed to hold scientific treasures. That quest by Russian, British and American scientific teams for water samples is the topic of an article in the current edition of Chemical & Engineering News, the weekly newsmagazine of the American Chemical Society (ACS), the world's largest scientific ...
2012-03-01
A novel system for processing embryos during IVF treatment has been shown to significantly improve the chances of pregnancy – by more than a quarter.
Pioneered by a Newcastle team of fertility experts at the University and within the NHS, the innovative design of interlinked incubators provides a totally enclosed and controlled environment within which every step of the IVF process can be performed.
Research published today in the journal PLoS ONE reveals that the introduction of the new system into the Newcastle Fertility Centre at Life, part of the Newcastle Hospitals ...
2012-03-01
COLUMBIA, Mo. – In 2007, a controversial pesticide was approved by the Food and Drug Administration for use on fruit and vegetable crops, mainly in California and Florida. Farm workers and scientists protested the approval of the pesticide because its active ingredient, methyl iodide, is a known carcinogen. Now, MU researchers are studying the molecular structure of the pesticide to determine if the product could be made more efficient and safer for those living near, and working in, treated fields.
Methyl iodide is the active ingredient used in a pesticide known commercially ...
LAST 30 PRESS RELEASES:
[Press-News.org] New hybrid 'NOSH aspirin' as possible anti-cancer drug